中信股份(00267.HK):興澄合金擬對興澄特鋼提供9億元擔保
格隆匯 8 月 3日丨中信股份(00267.HK)發佈公告,中信特鋼(000708.SZ)的全資孫公司江陰興澄合金材料有限公司(以下簡稱“興澄合金”)擬對全資子公司江陰興澄特種鋼鐵有限公司(以下簡稱“興澄特鋼”)提供9億元擔保。
興澄合金於8月份在江陰與廣發銀行江陰支行簽署《最高額保證合同》,為興澄特鋼在廣發銀行申請的9億元綜合授信提供全額連帶責任擔保,擔保期限為主債務合同債務期限屆滿之日起兩年。本次擔保已經由興澄合金於8月3日召開的董事會及股東審議通過,本次擔保事項無須提交中信特鋼董事會或股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.